Stay updated on LN-145 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the LN-145 in Solid Tumors Clinical Trial page.

Latest updates to the LN-145 in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNo substantive changes detected between the two page screenshots; core sections such as Brief Summary, Objectives, Eligibility Criteria, Endpoints, and Contacts appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedKey changes: added notice about funding-related site status and new topic “Bone osteosarcoma” with a new revision v3.2.0; removed the term “Thyroid gland undifferentiated (anaplastic) carcinoma” and the older revision v3.1.0.SummaryDifference2%

- Check45 days agoChange DetectedExpanded core content to include broader cancer, immunology, and musculoskeletal topics and updated the page version to v3.1.0; removed older, more specific terms and the older revision tag.SummaryDifference2%

- Check59 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No substantive content changes detected.SummaryDifference0.1%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

- Check73 days agoChange DetectedThe web page has been updated to include new drug information and resources related to various cancers, while several outdated terms and specific cancer types have been removed.SummaryDifference7%

Stay in the know with updates to LN-145 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-145 in Solid Tumors Clinical Trial page.